These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 826925)

  • 1. Behavioral evidence for dopaminergic supersensitivity following chronic treatment with methadone or chlorpromazine in the guinea pig.
    Eibergen RD; Carlson KR
    Psychopharmacology (Berl); 1976 Jul; 48(2):139-46. PubMed ID: 826925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyskinesias in monkeys: interaction of methamphetamine with prior methadone treatment.
    Eibergen RD; Carlson KR
    Pharmacol Biochem Behav; 1976 Aug; 5(2):175-87. PubMed ID: 825885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral supersensitivity to apomorphine following chronic narcotic treatment in the guinea pig.
    Carlson KR; Almasi J
    Psychopharmacology (Berl); 1978 May; 57(3):273-7. PubMed ID: 97708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between daily dosage of chlorpromazine and subsequent supersensitivity.
    Klawans HL; Carvey P; Hitri A; Nausieda PA; Weiner WJ
    Adv Biochem Psychopharmacol; 1980; 24():569-72. PubMed ID: 7190763
    [No Abstract]   [Full Text] [Related]  

  • 5. Catalepsy and stereotypies in rats treated with methadone; relation to striatal dopamine.
    Ahtee L
    Eur J Pharmacol; 1974 Jul; 27(2):221-30. PubMed ID: 4859239
    [No Abstract]   [Full Text] [Related]  

  • 6. An experimental model of tardive dyskinesia.
    Klawans HL; Rubovits R
    J Neural Transm; 1972; 33(3):235-46. PubMed ID: 4674512
    [No Abstract]   [Full Text] [Related]  

  • 7. Time course of dopaminergic hypersensitivity following chronic narcotic treatment.
    Carlson KR; Almasi J
    Pharmacol Biochem Behav; 1979 Sep; 11(3):283-7. PubMed ID: 574284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility to amphetamine-elicited dyskinesias following chronic methadone treatment in monkeys.
    Carlson KR; Eibergen RD
    Ann N Y Acad Sci; 1976; 281():336-49. PubMed ID: 828468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methamphetamine-induced behavioral alterations following repeated administration of methamphetamine.
    Yamanaka Y; Takano R; Egashira T
    Jpn J Pharmacol; 1986 Jun; 41(2):147-54. PubMed ID: 3091891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered behavioral responses to intense foot shock in socially-isolated rats.
    Nishikawa T; Tanaka M
    Pharmacol Biochem Behav; 1978 Jan; 8(1):61-7. PubMed ID: 564514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The specificity of neuroleptic- and methysergide-induced behavioral hypersensitivity.
    Klawans HL; D'amico DJ; Nausieda PA; Weiner WJ
    Psychopharmacology (Berl); 1977 Nov; 55(1):49-52. PubMed ID: 414261
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic nicotine treatment potentiates behavioral responses to dopaminergic drugs in rats.
    Suemaru K; Gomita Y; Furuno K; Araki Y
    Pharmacol Biochem Behav; 1993 Sep; 46(1):135-9. PubMed ID: 7902980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulpiride injection into the dorsal striatum increases methamphetamine-induced gnawing in rats.
    Koshikawa N; Aoki S; Tomiyama K; Maruyama Y; Kobayashi M
    Eur J Pharmacol; 1987 Jan; 133(1):119-25. PubMed ID: 3556388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of antagonists of NMDA receptor on methamphetamine-induced decrease in the dopamine uptake sites in the rat striatum and on the behavioral sensitization].
    Muraki A
    Hokkaido Igaku Zasshi; 1993 May; 68(3):407-18. PubMed ID: 8319937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of prenatal methadone on reinstated behavioral sensitization induced by methamphetamine in adolescent rats.
    Wong CS; Lee YJ; Chiang YC; Fan LW; Ho IK; Tien LT
    Behav Brain Res; 2014 Jan; 258():160-5. PubMed ID: 24157336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotypy and striatal dopamine receptor changes with 1-alpha-acetylmethadol (LAAM).
    Langley AE; Kirlangitis J; Lehman T
    Pharmacol Biochem Behav; 1981 May; 14(5):753-6. PubMed ID: 7195581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic-induced reduction of quipazine-elicited head-twitches in rats: possible involvement of striatal dopaminergic supersensitivity.
    Dall'Olio R; Vaccheri A; Gandolfi O; Roncada P; Montanaro N
    Pharmacol Biochem Behav; 1988 Dec; 31(4):941-4. PubMed ID: 2908069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and behavioral antagonism between fenfluramine and apomorphine in rats.
    Jori A; Cecchetti G; Ghezzi D; Samanin R
    Eur J Pharmacol; 1974 May; 26(2):179-83. PubMed ID: 4859224
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhancing effects of morphine on methamphetamine-induced reinforcing behavior and its association with dopamine release and metabolism in mice.
    Lan KC; Chang AC; Liu SH; Ho IK; Lin-Shiau SY
    J Neurochem; 2009 Apr; 109(2):382-92. PubMed ID: 19245664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment.
    Nishikawa T; Mataga N; Takashima M; Toru M
    Eur J Pharmacol; 1983 Mar; 88(2-3):195-203. PubMed ID: 6133769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.